secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001140361-24-029588
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ionis shareholders elect directors and approve all proposals at 2024 AGM
------------------------------------------------------------------------

- Brett P. Monia re-elected with 120.5M votes for, 2.9M against; Michael Yang re-elected with 109.1M for, 14.2M against.
- Advisory say-on-pay approved with 118.9M for, 4.2M against (96.6% support).
- Amendment to 2011 Equity Incentive Plan to increase shares by 3.3M to 38.5M approved (96.5M for, 26.9M against).
- Ratification of Ernst & Young as independent auditors approved with 129.9M for, 3.5M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000114036124029588/0001140361-24-029588-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000114036124029588/ef20030961_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-029588

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer